Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Rodriguez E, Pei G, Zhao Z, Kim ST, German A, Robinson P. Erratum: Rodriguez et al. Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis. Cancers 2021, 13, 3871. Cancers (Basel) 2021;13:5178. [PMID: 34680400 DOI: 10.3390/cancers13205178] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2021] [Accepted: 10/09/2021] [Indexed: 11/24/2022] Open

For:	Rodriguez E, Pei G, Zhao Z, Kim ST, German A, Robinson P. Erratum: Rodriguez et al. Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis. Cancers 2021, 13, 3871. Cancers (Basel) 2021;13:5178. [PMID: 34680400 DOI: 10.3390/cancers13205178] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2021] [Accepted: 10/09/2021] [Indexed: 11/24/2022] Open

Number

Cited by Other Article(s)

Coveñas R, Muñoz M. Involvement of the Substance P/Neurokinin-1 Receptor System in Cancer. Cancers (Basel) 2022;14:3539. [PMID: 35884599 PMCID: PMC9317685 DOI: 10.3390/cancers14143539] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2022] [Accepted: 07/19/2022] [Indexed: 02/05/2023] Open